This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.

Volume: 26, Issue: 2B, Pages: 1495 - 9
Published: Apr 20, 2006
Abstract
To determine the optimum dose of OK-432 for intrathoracic administration, a multicenter randomized phase II trial was conducted in patients with malignant pleural effusion due to non-small cell lung cancer. Patients with histologically- or cytologically-proven malignant pleural effusions were randomized to arm A (10 Klinische Einheit (KE) of OK-432) or arm B (1 KE of OK-432). OK-432 was injected intrapleurally over 30 min on days 1 and 3 and the...
Paper Details
Title
Randomized phase II trial of OK-432 in patients with malignant pleural effusion due to non-small cell lung cancer.
Published Date
Apr 20, 2006
Journal
Volume
26
Issue
2B
Pages
1495 - 9
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.